PL3606909T3 - Sól sodowa N-((1,2,3,5,6,7-heksahydro-s-indacen-4-ylo)karbamoilo)-1-izopropylo-1H-pirazolo-3-sulfonamidu - Google Patents
Sól sodowa N-((1,2,3,5,6,7-heksahydro-s-indacen-4-ylo)karbamoilo)-1-izopropylo-1H-pirazolo-3-sulfonamiduInfo
- Publication number
- PL3606909T3 PL3606909T3 PL19721230T PL19721230T PL3606909T3 PL 3606909 T3 PL3606909 T3 PL 3606909T3 PL 19721230 T PL19721230 T PL 19721230T PL 19721230 T PL19721230 T PL 19721230T PL 3606909 T3 PL3606909 T3 PL 3606909T3
- Authority
- PL
- Poland
- Prior art keywords
- indacen
- hexahydro
- sulfonamide
- pyrazole
- carbamoyl
- Prior art date
Links
- MTOUOUSKXWSTAX-UHFFFAOYSA-N 1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-3-(1-propan-2-ylpyrazol-3-yl)sulfonylurea Chemical compound C1CCC2=C(C=3CCCC=3C=C12)NC(=O)NS(=O)(=O)C1=NN(C=C1)C(C)C MTOUOUSKXWSTAX-UHFFFAOYSA-N 0.000 title 1
- 159000000000 sodium salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1806578.9A GB201806578D0 (en) | 2018-04-23 | 2018-04-23 | Novel compound |
| PCT/EP2019/060311 WO2019206871A1 (en) | 2018-04-23 | 2019-04-23 | A sodium salt of n-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-1 -isopropyl-1 h-pyrazole-3-sulfonamide |
| EP19721230.1A EP3606909B1 (en) | 2018-04-23 | 2019-04-23 | A sodium salt of n-((1,2,3,5,6,7-hexahydro-s-indacen-4 -yl)carbamoyl)-1-isopropyl-1h-pyrazole-3-sulfonamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3606909T3 true PL3606909T3 (pl) | 2020-11-16 |
Family
ID=62236309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19721230T PL3606909T3 (pl) | 2018-04-23 | 2019-04-23 | Sól sodowa N-((1,2,3,5,6,7-heksahydro-s-indacen-4-ylo)karbamoilo)-1-izopropylo-1H-pirazolo-3-sulfonamidu |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US10973803B2 (pl) |
| EP (2) | EP3722281A1 (pl) |
| JP (1) | JP7382958B2 (pl) |
| KR (1) | KR20210005589A (pl) |
| CN (1) | CN112020495B (pl) |
| AR (1) | AR114827A1 (pl) |
| AU (1) | AU2019257973A1 (pl) |
| BR (1) | BR112020021650A2 (pl) |
| CA (1) | CA3097832A1 (pl) |
| CY (1) | CY1123260T1 (pl) |
| DK (1) | DK3606909T3 (pl) |
| ES (1) | ES2811228T3 (pl) |
| GB (1) | GB201806578D0 (pl) |
| HR (1) | HRP20201263T1 (pl) |
| HU (1) | HUE050369T2 (pl) |
| LT (1) | LT3606909T (pl) |
| MA (2) | MA51082A (pl) |
| MD (1) | MD3606909T2 (pl) |
| ME (1) | ME03822B (pl) |
| MX (1) | MX2020011196A (pl) |
| PL (1) | PL3606909T3 (pl) |
| PT (1) | PT3606909T (pl) |
| RS (1) | RS60646B1 (pl) |
| SI (1) | SI3606909T1 (pl) |
| SM (1) | SMT202000448T1 (pl) |
| TW (1) | TW201943704A (pl) |
| UY (1) | UY38186A (pl) |
| WO (1) | WO2019206871A1 (pl) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3047336A1 (en) | 2017-01-23 | 2018-07-26 | Jecure Therapeutics, Inc. | Chemical compounds as inhibitors of interleukin-1 activity |
| US11840543B2 (en) | 2017-05-24 | 2023-12-12 | The University Of Queensland | Compounds and uses |
| EP3649112A1 (en) | 2017-07-07 | 2020-05-13 | Inflazome Limited | Sulfonylureas and sulfonylthioureas as nlrp3 inhibitors |
| EP3668840A1 (en) | 2017-08-15 | 2020-06-24 | Inflazome Limited | Novel sulfonamide carboxamide compounds |
| TW201910317A (zh) | 2017-08-15 | 2019-03-16 | 愛爾蘭商英弗雷佐姆有限公司 | 新穎化合物 |
| US11773058B2 (en) | 2017-08-15 | 2023-10-03 | Inflazome Limited | Sulfonamide carboxamide compounds |
| EP3668843A1 (en) | 2017-08-15 | 2020-06-24 | Inflazome Limited | Sulfonylureas and sulfonylthioureas as nlrp3 inhibitors |
| TW201910316A (zh) | 2017-08-15 | 2019-03-16 | 愛爾蘭商英弗雷佐姆有限公司 | 新穎化合物 |
| EP3707137A1 (en) | 2017-11-09 | 2020-09-16 | Inflazome Limited | Novel sulfonamide carboxamide compounds |
| PE20210050A1 (es) | 2017-11-09 | 2021-01-08 | Inflazome Ltd | Nuevos compuestos de sulfonamida carboxamida |
| US11884645B2 (en) | 2018-03-02 | 2024-01-30 | Inflazome Limited | Sulfonyl acetamides as NLRP3 inhibitors |
| EP3759073A1 (en) | 2018-03-02 | 2021-01-06 | Inflazome Limited | Sulfonamide derivates as nlrp3 inhibitors |
| US12030879B2 (en) | 2018-03-02 | 2024-07-09 | Inflazome Limited | Sulfonyl acetamides as NLRP3 inhibitors |
| WO2019166619A1 (en) | 2018-03-02 | 2019-09-06 | Inflazome Limited | Novel compounds |
| WO2019166627A1 (en) | 2018-03-02 | 2019-09-06 | Inflazome Limited | Novel compounds |
| US11530200B2 (en) | 2018-03-02 | 2022-12-20 | Inflazome Limited | Compounds |
| GB201806578D0 (en) | 2018-04-23 | 2018-06-06 | Inflazome Ltd | Novel compound |
| BR112021001044A2 (pt) | 2018-07-20 | 2021-04-13 | F. Hoffmann-La Roche Ag | Compostos de sulfonimidamida como inibidores da atividade de interleucina-1 |
| CA3104199A1 (en) | 2018-07-20 | 2020-01-23 | F. Hoffmann-La Roche Ag | Sulfonylurea compounds as inhibitors of interleukin-1 activity |
| GB201817038D0 (en) | 2018-10-19 | 2018-12-05 | Inflazome Ltd | Novel processes |
| EP4054564A1 (en) * | 2019-11-07 | 2022-09-14 | Inflazome Limited | Treatment of autoinflammatory disorders |
| EP4076441A2 (en) * | 2019-11-07 | 2022-10-26 | Inflazome Limited | Treatment and prevention of a neurodegenerative disorder |
| WO2021089781A1 (en) * | 2019-11-07 | 2021-05-14 | Inflazome Limited | Treatment or prevention of psychiatric brain disorders using the nlrp3 inhibitor n-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-1 -isopropyl-1 h-pyrazole-3-sulfonamide |
| GB201916237D0 (en) * | 2019-11-07 | 2019-12-25 | Inflazome Ltd | Novel treatment |
| CN114630664A (zh) * | 2019-11-07 | 2022-06-14 | 英夫拉索姆有限公司 | 神经炎症或炎性脑部病症的治疗和预防 |
| WO2021089776A1 (en) * | 2019-11-07 | 2021-05-14 | Inflazome Limited | Treatment and prevention of a traumatic brain disorder |
| JP7843705B2 (ja) | 2020-01-22 | 2026-04-10 | エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト | Ｎｌｒｐ３モジュレーターとしてのスルホンイミドアミド化合物 |
| WO2022023907A1 (en) | 2020-07-31 | 2022-02-03 | Novartis Ag | Methods of selecting and treating patients at elevated risk of major adverse cardiac events |
| WO2025153532A1 (en) | 2024-01-16 | 2025-07-24 | NodThera Limited | Nlrp3 inhibitors and glp-1 agonists combination therapies |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4802908A (en) * | 1987-01-22 | 1989-02-07 | E. I. Du Pont De Nemours And Company | Herbicidal 2-(1H)-pyrazinones |
| EP1214087A1 (en) * | 1999-09-14 | 2002-06-19 | Pfizer Products Inc. | Combination treatment with il-1ra and compounds that inhibit il-1 processing and release |
| EP2781216A4 (en) * | 2011-09-02 | 2015-05-27 | Kyowa Hakko Kirin Co Ltd | CHEMOKINREZEPTORAKTIVITÄTSREGLER |
| HUE055755T2 (hu) * | 2015-02-16 | 2021-12-28 | Univ Queensland | Szulfonolkarmabidok és rokon vegyületeik valamint felhasználásuk |
| FR3046933B1 (fr) | 2016-01-25 | 2018-03-02 | Galderma Research & Development | Inhibiteurs nlrp3 pour le traitement des pathologies cutanees inflammatoires |
| HK1257569A1 (zh) | 2016-02-16 | 2019-10-25 | The University Of Queensland | 磺醯脲和相关化合物及其用途 |
| US11339136B2 (en) | 2016-04-18 | 2022-05-24 | Novartis Ag | Compounds and compositions for treating conditions associated with NLRP activity |
| WO2017184604A1 (en) | 2016-04-18 | 2017-10-26 | Ifm Therapeutics, Inc | Compounds and compositions for treating conditions associated with nlrp activity |
| EP3272739A1 (en) | 2016-07-20 | 2018-01-24 | NodThera Limited | Sulfonyl urea derivatives and their use in the control of interleukin-1 activity |
| GB201806578D0 (en) | 2018-04-23 | 2018-06-06 | Inflazome Ltd | Novel compound |
| GB201817038D0 (en) | 2018-10-19 | 2018-12-05 | Inflazome Ltd | Novel processes |
-
2018
- 2018-04-23 GB GBGB1806578.9A patent/GB201806578D0/en not_active Ceased
-
2019
- 2019-04-23 MX MX2020011196A patent/MX2020011196A/es unknown
- 2019-04-23 PT PT197212301T patent/PT3606909T/pt unknown
- 2019-04-23 AR ARP190101056A patent/AR114827A1/es not_active Application Discontinuation
- 2019-04-23 ME MEP-2020-173A patent/ME03822B/me unknown
- 2019-04-23 KR KR1020207030023A patent/KR20210005589A/ko not_active Ceased
- 2019-04-23 HU HUE19721230A patent/HUE050369T2/hu unknown
- 2019-04-23 MD MDE20200181T patent/MD3606909T2/ro not_active IP Right Cessation
- 2019-04-23 JP JP2020557902A patent/JP7382958B2/ja active Active
- 2019-04-23 UY UY0001038186A patent/UY38186A/es not_active Application Discontinuation
- 2019-04-23 ES ES19721230T patent/ES2811228T3/es active Active
- 2019-04-23 EP EP20176198.8A patent/EP3722281A1/en not_active Withdrawn
- 2019-04-23 CA CA3097832A patent/CA3097832A1/en active Pending
- 2019-04-23 PL PL19721230T patent/PL3606909T3/pl unknown
- 2019-04-23 SM SM20200448T patent/SMT202000448T1/it unknown
- 2019-04-23 AU AU2019257973A patent/AU2019257973A1/en not_active Abandoned
- 2019-04-23 MA MA051082A patent/MA51082A/fr unknown
- 2019-04-23 TW TW108114167A patent/TW201943704A/zh unknown
- 2019-04-23 MA MA48051A patent/MA48051B1/fr unknown
- 2019-04-23 RS RS20200936A patent/RS60646B1/sr unknown
- 2019-04-23 LT LTEP19721230.1T patent/LT3606909T/lt unknown
- 2019-04-23 BR BR112020021650-0A patent/BR112020021650A2/pt not_active Application Discontinuation
- 2019-04-23 CN CN201980026640.0A patent/CN112020495B/zh active Active
- 2019-04-23 WO PCT/EP2019/060311 patent/WO2019206871A1/en not_active Ceased
- 2019-04-23 EP EP19721230.1A patent/EP3606909B1/en active Active
- 2019-04-23 SI SI201930005T patent/SI3606909T1/sl unknown
- 2019-04-23 DK DK19721230.1T patent/DK3606909T3/da active
- 2019-04-23 HR HRP20201263TT patent/HRP20201263T1/hr unknown
-
2020
- 2020-04-16 US US16/850,978 patent/US10973803B2/en active Active
- 2020-08-12 CY CY20201100756T patent/CY1123260T1/el unknown
-
2021
- 2021-03-09 US US17/196,956 patent/US20210315862A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LT3606909T (lt) | N-((1,2,3,5,6,7-heksahidro-s-indacen-4 -il)karbamoil)-1-izopropil-1h-pirazol-3-sulfonamido natrio druska | |
| IL286871A (en) | Diazine-amide compounds are active as pesticides | |
| IL286422A (en) | Diazine-amide compounds are active as pesticides | |
| IL275761A (en) | Benzamide compounds | |
| PH12018502136A1 (en) | Heterocyclic amides useful as protein modulators | |
| EP3814332C0 (en) | PESTICIDES AZOLE AMIDE ACTIVE INGREDIENTS | |
| PH12020500673A1 (en) | Compounds | |
| MX379169B (es) | Amidas heterocíclicas útiles como moduladores de proteínas. | |
| JOP20200059A1 (ar) | مركبات تنشيط القسيم العضلي ثنائي الأميد واستخداماتها | |
| CA196171S (en) | Head strap | |
| PL3317272T3 (pl) | Chwastobójczo skuteczne pochodne N-(1,3,4-oksadiazol-2-ilo)arylokarboksyamidowe | |
| IL260665B (en) | Improved process for the preparation of osimertinib (azd9291) or its salt and "azd9291 aniline" or its salt | |
| IL282905A (en) | Cycloalkane-1, 3-diamine derivative | |
| IL288575A (en) | N-(pyrid-3-yl)carboxamides fungicides | |
| EP3856174A4 (en) | HDAC1, 2 INHIBITORS | |
| SG11202104371XA (en) | 1,3,4-oxadiazolone compound and pharmaceutical | |
| IL310956A (en) | common crystal | |
| IL291570A (en) | Pharmaceutical preparations | |
| GB202110403D0 (en) | Ulodesine Salt | |
| IL276196B1 (en) | Synthesis of 5-chloro-2-[(3,4,4-trifluoro-3-buten-1-yl)thio]-thiazole | |
| WO2017191619A3 (en) | A process for the preparation of a salt of sacubitril and valsartan | |
| LT3592734T (lt) | (1r,3s)-3-(5-ciano-4-fenil-1,3-tiazol-2-ilkarbamoil)ciklopentankarboksirūgšties amino druska | |
| GB201809458D0 (en) | Salt form | |
| PL3153022T3 (pl) | N-(3’,4’-dichloro-5-metoksybifenyl-2-ylo)-3-(difluorometylo)-1-metylo-1H-pirazolo-4-karboksyamid | |
| AR101109A1 (es) | Forma polimórfica del clorhidrato de n-[2-(6-fluoro-1h-indol-3-il)etil]-3-(2,2,3,3-tetrafluoropropoxi)bencilamina |